Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multicenter, Randomized, Follow-up Study to Evaluate the Long-Term Safety of Clonidine Micropellets for the Treatment of Pain Associated With Lumbosacral Radiculopathy in Adults

Trial Profile

A Multicenter, Randomized, Follow-up Study to Evaluate the Long-Term Safety of Clonidine Micropellets for the Treatment of Pain Associated With Lumbosacral Radiculopathy in Adults

Recruiting
Phase of Trial: Phase III

Latest Information Update: 17 Jan 2019

At a glance

  • Drugs Clonidine (Primary)
  • Indications Sciatica
  • Focus Registrational; Therapeutic Use
  • Acronyms RePRIEVE-CM
  • Sponsors Sollis Therapeutics
  • Most Recent Events

    • 16 Nov 2018 According to Sollis Therapeutics media release, first patient has been enrolled in this trial. Dr. Richard Vaglienti (Director of the Center for Integrative Pain Management) is the principal investigator at West Virginia University) and Dr. Christopher Gilligan, (Chief of the Pain Medicine Division at Brigham and Women's Hospital and Assistant Professor at Harvard Medical School) is the overall trial principal investigator.
    • 16 Nov 2018 Status changed from planning to recruiting, according to Sollis Therapeutics media release.
    • 25 Apr 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top